← Back to all earnings calls

Serina Therapeutics, Inc. Q1 FY2023 Earnings Call

Serina Therapeutics, Inc. (SER)

Earnings Call FY2023 Q1 Call date: 2023-05-12 Concluded

Share

Quarter scorecard

Revenue

$30,000

+500% YoY

Diluted EPS

$0.20

Gross margin

30.0%

-50.0 pp YoY

Net income

$1.66M

Documents & deck